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which was incident upon the target. The resulting bremsstrahlung x-
ray beam was then propagated through the simulated machine and 
into a phantom. A scoring plane at the surface of the phantom was 
used to compute the backscatter factor (Bw) and the mass-energy 
absorption coefficient ratio [(μen/ρ)w/air]air. The chamber factor (kch) 
was also measured experimentally by comparing the chamber reading 
with the dose obtained using the backscatter-factor method. 
Results: The HVL was calculated to be 0.9 mm Al similar to the 
experimental value of 0.77 mm Al. Simulated PDD curves agreed well 
with previous measurements. The mass-energy absorption coefficient 
for water to air at the surface of a water phantom was found to be 
1.023 + 0.001 consistent with the value in the current UK code of 
practice for the same quality index. The backscatter factor was 
estimated to be 1.05 + 0.005 for an 11 mm field radius as shown by 
Figure 1. This reduces the value of a dose measurement by 
approximately 1% relative to the current UK code of practice value 
based on published studies. The value of the chamber correction 
factor kch obtained through measurement using low and very low 
energy codes was 1.04 + 0.01, lower than the 1.06 currently in the 
code of practice but within the uncertainties in the original studies. 
 
 
Conclusions: The values for the calibration coefficients generated in 
this study are close to those in the UK code of practice. A difference 
of 2% was found for the chamber factor but this coefficient is known 
to be subject to large uncertainties of which the code of practice 
gives a representative value. Work is continuing to model the 
PTW23342 ionisation chamber and produce a chamber factor via 
Monte Carlo simulation. Initial results are higher than experimental 
values. 
   
OC-0436   
On the latent variance of the vendor supplied TrueBeam phase 
space files 
R.O. Cronholm1, C.F. Behrens2 
1Skåne University Hospital, Radiation Physics, Lund, Sweden  
2University Hospital Herlev, Medical Physics, Herlev, Denmark 
 
Purpose/Objective: For the TrueBeamTM linac, the vendors (Varian 
Medical Systems) only include detailed information on the components 
from the secondary collimators and downstreams in their Monte Carlo 
data package. In order to describe the upper part of the TrueBeam 
linac the vendor supply phase space files (PSF). This leads to 
consequences for the user; it is no longer possible to commission the 
Monte Carlo (MC) model against a specific linac. Moreover, the 
number of unique particles is limited by the size of the PSF, thereby 
limiting the achievable accuracy in dose calculations. The term 'latent 
variance' was coined by Sempau et al. (2001) and refers to the limit on 
the achievable total variance as a consequence of the number of 
particles in the PSF being finite. The purpose of this study was to 
determine the latent standard deviation of the vendor supplied 
TrueBeam PSFs for a clinically relevant situation  
Materials and Methods: The total variance of a patient and/or 
phantom simulation is a combination of the latent variance of the PSF, 
A, and the statistical variance of the dose scoring simulation, B. 
  
where N is the number of simulated histories.  
By employing a K-fold recycling of the PSF particles equation 1 can be 
rewritten as 
 
 The total variance can be represented as a function of K-1 and fitted 
to a straight line. The latent variance of the PSF is given by the 
crossing of this line with the axis K-1=0.  
The most recent TrueBeam PSFs were downloaded from 
myVarian.com. A 10×10 cm2 field was simulated in BEAMnrc using 
combined and trigometrically 'flattened' PSFs for each energy and 
fluence mode as input. No variance reductions were employed and 
PSFs were scored at 90 cm SSD. 
DOSXYZnrc was employed to score dose in a 40×40×40 cm3 
homogeneous water phantom using the 10×10 cm2 field PSFs as input 
directly on the phantom surface. The voxel size was 0.25×0.25×0.25 
cm3 and the variance in the 27 voxels located around the beam 
isocenter was scored.  
Results: The total variance, q, as a function of the inverse recycling 
rate, K-1, is shown in figure 1. The latent SD for each energy and mode 
is shown in table 1. 
 
  
Table 1. Absolute and relative latent standard deviation for each 
energy and mode studied. The relative latent standard deviation is 
given with respect to the dose of the isocenter voxel. 
Nominal 
Energy 
(MeV) 
Mode Latent SD 
(eV cm2 g-1 per 
history) 
Relative Latent 
SD  
(%) 
6 Flattened 6.13±0.46 1.02±0.08 
6 FFF 13.07±0.98 0.85±0.14 
10 Flattened 12.04±1.94 0.74±0.06 
10 FFF 26.45±1.58 0.41±0.02 
 
Conclusions: The latent SDs of the vendor supplied TrueBeam PSFs 
were determined for a clinically relevant situation. The latent SD is 
most likely sufficiently low for many applications (e.g. MC based 
patient specific QA), but inadequate if the goal is to perform 
simulations requiring a high level of accuracy (e.g.computation of 
correction factors). MC is often considered the golden standard in 
comparison of dose calculation algorithms. Regardless of the level of 
the latent SD, such studies would be biased as other algorithms 
typically are based on dose measurements for a specific linac, 
whereas the PSFs are generic.  
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Purpose/Objective: In proton therapy, complex density 
heterogeneities within the beam path pose a challenge to analytical 
dose calculation algorithms so that the reliability of the predicted 
dose distributions might be questioned. For these cases in which 
substantial dose errors are expected, resorting to more accurate 
Monte Carlo (MC) simulations might be essential to ensure a successful 
treatment outcome and therefore the benefit is worth a presumably 
long computation time. The aim of this study was to obtain a 
geometrical indicator for the accuracy of dose delivery based on 
analytical dose calculations for proton therapy fields. 
